Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease

Journal of Alzheimer's Disease

Volumn 35, Issue 1, 2013, Pages 169-178

  Van Der Vlies, Annelies E ^a   Staekenborg, Salka S ^a   Admiraal Behloul, Faiza ^b   Prins, Niels D ^a   Barkhof, Frederik ^c   Vrenken, Hugo ^a,c   Reiber, Johan H C ^b   Scheltens, Philip ^a   Van Der Flier, Wiesje M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age of onset; Alzheimer's disease; cognition; magnetic resonance imaging

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; BRAIN ATROPHY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL CAPACITY; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; WHITE MATTER; WORKING MEMORY;

EID: 84876372591     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121291     Document Type: Article

References (48)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
2. Risacher SL, Saykin AJ,West JD, Shen L, Firpi HA, McDonald BC (2009) Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 6, 347-361.
3. Karas GB, Scheltens P, Rombouts SARB,Visser PJ, van Schijndel RA, Fox NC, Barkhof F (2004) Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 23, 708-716. (Pubitemid 39370621)
4. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403. (Pubitemid 44108123)
5. Henneman WJP, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F (2009) Hippocampal atrophy rates in Alzheimer disease Added value over whole brain volume measures. Neurology 72, 999-1007.
6. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E (2000) Impact of white matter changes on clinical manifestation of Alzheimer's disease - A quantitative study. Stroke 31, 2182-2188.
7. Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, Norman D, Mack WJ, Willis L, Chui HC (2001) MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 57, 2229-2235. (Pubitemid 34016456)
8. Stout JC, Jernigan TL, Archibald SL, Salmon DP (1996) Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch Neurol 53, 742-749. (Pubitemid 26266919)
9. Swartz RH, Stuss DT, Gao F, Black SE (2008) Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke 39, 822-830. (Pubitemid 351619545)
10. De Leeuw FE, De Groot JC, Achten E, Oudkerk M, Ramos LMP, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MMB (2001) Prevalence of cerebral white matter lesions in elderly people:Apopulation based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70, 9-14. (Pubitemid 32096113)
11. Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ (2008) Heterogeneity of white matter hyperintensities in Alzheimer's disease: Post-mortem quantitative MRI and neuropathology. Brain 131, 3286-3298.
12. Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ (2011) Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 82, 126-135.
13. Bracco L, Piccini C, Moretti M, Mascalchi M, Sforza A, Nacmias B, Cellini E, Bagnoli S, Sorbi S (2005) Alzheimer's disease: Role of size and location of white matter changes in determining cognitive deficits. Dement Geriatr Cogn Disord 20, 358-366. (Pubitemid 41642794)
14. Gootjes L, Teipel SJ, Zebuhr Y, Schwarz R, Leinsinger G, Scheltens P, Moller HJ, Hampel H (2004) Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord 18, 180-188. (Pubitemid 39140369)
15. Burns JM, Church JA, Johnson DK, Xiong CJ, Marcus D, FotenosAF, Snyder AZ, Morris JC, BucknerRL(2005) White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch Neurol 62, 1870-1876. (Pubitemid 41785081)
16. Kavcic V, Ni HY, Zhu T, Zhong JH, Duffy CJ (2008) White matter integrity linked to functional impairments in aging and early Alzheimer's disease. Alzheimers Dement 4, 381-389.
17. Baxter LC, Sparks DL, Johnson SC, Lenoski B, Lopez JE, Connor DJ, Sabbagh MN (2006) Relationship of cognitive measures and gray and white matter in Alzheimer's disease. J Alzheimers Dis 9, 253-260. (Pubitemid 44253343)
18. Wahlund LO, Basun H, Almkvist O, Anderssonlundman G, Julin P, Saaf J (1994) White-matter hyperintensities in dementia - does it matter. Magn Reson Imag 12, 387-394. (Pubitemid 24113181)
19. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ (2004) White matter lesions impair frontal lobe function regardless of their location. Neurology 63, 246-253. (Pubitemid 38971122)
20. Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, Beltramello A, Hayashi KM, Toga AW, Thompson PM (2007) The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 130, 720-730. (Pubitemid 46410740)
21. Ishii K, Kawachi T, Sasaki H, Kono AK, Fukuda T, Kojima Y, Mori E (2005) Voxel-based morphometric comparison between early-and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am J Neuroradiol 26, 333-340. (Pubitemid 43073309)
22. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
23. Verhage F (1964) Intelligentie en Leeftijd: Onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar [Intelligence and Age: Study with Dutch people aged 12 to 77], Van Gorcum, Assen.
24. van der Vlies AE, Verwey NA, Bouwman FH, Blankenstein MA, Klein M, Scheltens P, van der Flier WM (2009) CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. Neurology 72, 1056-1061.
25. Wechsler DA (1981) Wechsler Adult Intelligence Scale - Revised, The Psychological Corporation, New York.
26. Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C (2002) Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 73, 126-133.
27. Reitan R (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skills 8, 271-276.
28. Folstein MF, Folstein SE, Mchugh PR (1975) Mini-Mental State - practical method for grading cognitive state of patients for clinician. J Psychiatr Res 12, 189-198.
29. Staekenborg SS, de Waal H, Admiraal-Behloul F, Barkhof F, Reiber JHC, Scheltens P, PijnenburgYAL, Vrenken H, van der FlierWM(2010) Neurological signs in relation to white matter hyperintensity volumes in memory clinic patients. Dement Geriatr Cogn Disord 29, 301-308.
30. Admiraal-Behloul F, van den Heuvel DM, Olofsen H, van Osch MJ, van der Grond J, van BuchemMA,Reiber JH (2005) Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage 28, 607-617. (Pubitemid 41541964)
31. Zilles K, Rehkämper G (1998) Funktionelle Neuroanatomie: Lehrbuch und Atlas, Springer, Berlin.
32. Dave RN, KrishnapuramR(1997) Robust clustering methods: A unified view. Fuzzy Systems, IEEE Transactions on 5, 270-293. (Pubitemid 127768514)
33. van Es AC, van der Flier WM, Admiraal-Behloul F, Olofsen H, Bollen EL, Middelkoop HA, Weverling-Rijnsburger AW, van der Grond J, Westendorp RG, van Buchem MA (2007) Lobar distribution of changes in gray matter and white matter in memory clinic patients: Detected using magnetization transfer imaging. AJNR Am J Neuroradiol 28, 1938- 1942. (Pubitemid 350174739)
34. Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, Van Elk EJ, Scheltens P, Blankenstein MA (2010) Amyloid-beta (1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem 56, 248-253.
35. Perneczky R,Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, DeCarli C, Farrer LA, Kurz A (2010) Head circumference, atrophy, and cognition: Implications for brain reserve in Alzheimer disease. Neurology 75, 137-142.
36. Kertesz A, Polk M, Carr T (1990) Cognition and white matter changes on magnetic-resonance-imaging in dementia. Arch Neurol 47, 387-391. (Pubitemid 20132140)
37. Seltzer B, Sherwin I (1983) A comparison of clinical-features in early-onset and late-onset primary degenerative dementia - one entity or 2. Arch Neurol 40, 143-146. (Pubitemid 13139113)
38. Sevush S, Leve N, Brickman A (1993) Age at disease onset and pattern of cognitive impairment in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci 5, 66-72. (Pubitemid 23073813)
39. Greicius MD, Geschwind MD, Miller BL (2002) Presenile dementia syndromes: An update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry 72, 691-700. (Pubitemid 34557008)
40. Smits LL, Pijnenburg YA, Koedam EL, van der Vlies AE, Reuling IE, Koene T, Teunissen CE, Scheltens P, van der Flier WM (2012) Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 30, 101-108.
41. Sluimer JD, Vrenken H, BlankensteinMA,Fox NC, Scheltens P, Barkhof F, van der Flier WM (2008) Whole-brain atrophy rate in Alzheimer disease - Identifying fast progressors. Neurology 70, 1836-1841. (Pubitemid 351653952)
42. Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR Jr, Weiner M, DeCarli C (2010) Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol 67, 1370-1378.
43. Heo JH, Lee ST, Kon C, Park HJ, Shim JY, Kim M (2009) White matter hyperintensities and cognitive dysfunction in Alzheimer disease. J Geriatr Psychiatry Neurol 22, 207-212.
44. Almkvist O, Wahlund LO, Anderssonlundman G, Basun H, Backman L (1992) White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 49, 626-632.
45. Meier IB, Manly JJ, Provenzano FA, Louie KS, Wasserman BT, Griffith EY, Hector JT, Allocco E, Brickman AM (2012) White matter predictors of cognitive functioning in older adults. J Int Neuropsychol Soc 18, 414-427.
46. Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN (2012) Amyloid burden and metabolic function in early-onset Alzheimer's disease: Parietal lobe involvement. Brain 135, 2115-2125.
47. Buckner RL, WheelerME(2001) The cognitive neuroscience of remembering. Nat Rev Neurosci 2, 624-634. (Pubitemid 33674054)
48. van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal- Behloul F, van Es AC, Palm WM, Spilt A, Bollen EL, Blauw GJ, Launer L,Westendorp RG, van BuchemMA(2006) Measuring longitudinal white matter changes: Comparison of a visual rating scale with a volumetric measurement. AJNR Am J Neuroradiol 27, 875-878. (Pubitemid 44897739)